Laparoscopic single anastomosis sleeve-jejunal bypass for the treatment of morbidly obese patients: 1-year follow-up

Introduction The bariatric procedure known as single anastomosis sleeve-jejunal (SASJ) bypass is relatively new. By maintaining access to the duodenum, common bile duct stones can be removed endoscopically and secure in preventing long-term nutritional issues. This research assessed the efficacy of SASJ bypass surgery in treating individuals with morbid obesity and related comorbidities. Patients and methods Fifty individuals with severe obesity had SASJ bypass as part of this research. At 1, 6, and 12 months, all patients were followed-up. By measuring BMI, problems, and comorbidities connected to obesity, we analyzed every patient. Results The participants' average age was 35.2, and their average BMI was 49.8kg/m(2). Thirty-seven (74%) of the patients had type 2 diabetes, while 16 (32%) had hypertension. There was intraluminal bleeding in two (4%) cases, biliary gastritis in three (6%) individuals, and deep vein thrombosis in one (2%) patient. In a year, the excess weight loss reached 87%. In 91.9% of diabetes patients who had surgery, blood glucose levels returned to normal after a year. In 81.3% of hypertensive individuals, hypertension decreased. Conclusion Laparoscopic SASJ bypass is technically easy to perform and considered to be an efficient procedure for treating morbidly obese patients and comorbid conditions with minimal nutritional deficiency and a low incidence of complications.